Author

Jonathan M. van Eyll

UCB Pharma (Belgium)ORCID 0000-0002-9949-0526Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrée Delahaye‐DurieziD· 1 shared Bénédicte Danis· 1 shared Catherine Vandenplas· 1 shared Enrico G. PetrettoiD· 1 shared Frederic Vanclef· 1 shared Georges Mairet‐Coello· 1 shared Karine LeclercqiD· 1 shared Kirill ShkuraiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Andrée Delahaye‐DuriezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologybioRxivPreprintMay 22, 2017

A Systems-Level Framework For Drug Discovery Identifies Csf1R As A Novel Anti-Epileptic Drug Target

Prashant Kumar Srivastava, Jonathan M. van Eyll, Patrice Godard…·Michael R. Johnson

This paper introduces CRAFT, a computational framework for drug target identification, and validates Csf1R as a novel anti-epileptic target using pre-clinical models.

3 citations

statistical modeldrug response / drug discovery